Molecular architecture of G protein-coupled receptors

Drug Development Research

Volumn 37, Issue 1, 1996, Pages 1-38

  Van Rhee, A Michiel ^a   Jacobson, Kenneth A ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

G protein coupled receptors; GPCRs; Identifiers; Molecular architecture; Molecular structure; Mutagenesis; Sequence alignment; Transmembrane domains

Indexed keywords

BINDING PROTEIN; DRUG RECEPTOR; PROTEIN G; RECEPTOR SUBTYPE; RHODOPSIN;

AMINO ACID SEQUENCE; BINDING SITE; HUMAN; MUTATION; NONHUMAN; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN STRUCTURE; REVIEW; SEQUENCE HOMOLOGY;

EID: 0029919840     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199601)37:1<1::AID-DDR1>3.0.CO;2-S     Document Type: Review

References (312)

1. 1A receptor: low-stringency cloning and eukaryotic expression. J Chem Neuroanat 5:283-288.
2. Allard JW, Sigal IS, Dixon RA (1987): Sequence of the gene encoding the human M1 muscarinic acetylcholine receptor. Nucleic Acids Res 15:10604.
3. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S (1990): Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348:730-732.
4. Arakawa S, Gocayne JD, McCombie WR, Urquhart DA, Hall LM, Fraser CM, Venter JC (1990): Cloning, localization, and permanent expression of a Drosophila octopamine receptor. Neuron 4:343-354.
5. Baldwin JM (1993): The probable arrangement of the helices in G protein-coupled receptors. EMBO J 12:1693-1703.
6. Baldwin JM (1994): Structure and function of receptors coupled to G proteins. Curr Opinion Cell Biol 6:180-190.
7. Ballesteros JA, Weinstein H (1995): Integrated methods for the construction of three dimensional models and computational probing of structure-function relations in G-protein coupled receptors. Methods Neurosci 25:366-428.
8. Barberis C, Seibold A, Ishido M, Rosenthal W, Birnbaumer M (1993): Expression cloning of the human V2 vasopressin receptor. Regul Pept 45:61-66.
9. Baumgartner JW, Wells CA, Chen CM, Waters MJ (1994): The role of the WSXWS equivalent motif in growth hormone receptor function. J Biol Chem 269:29094-29101.
10. Beckmann MP, Munger WE, Kozlosky C, van den Bos T, Price V, Lyman S, Gerard NP, Gerard C, Cerretti DP (1991): Molecular characterization of the interleukin-8 receptor. Biochem Biophys Res Commun 179:784-789.
11. Beinborn M, Lee YM, McBride EW, Quinn SM, Kopin AS (1993): A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonists. Nature 362: 348-350.
12. 5 dopamine receptor: studies in primate brain and transfected mammalian cells. Proc Natl Acad Sci USA 92:3468-3472.
13. Bhogal N, Donnelly D, Findlay JB (1994): The ligand binding site of the neurokinin 2 receptor. Site-directed mutagenesis and identification of neurokinin A binding residues in the human neurokinin 2 receptor. J Biol Chem 269:27269-27274.
14. Bichet DG, Arthus MF, Lonergan M, Hendy GN, Paradis AJ, Fujiwara TM, Morgan K, Gregory MC, Rosenthal W, Didwania A, Antaramian A, Birnbaumer M (1993): X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis. J Clin Invest 92:1262-1268.
15. Bihoreau C, Monnot C, Davies E, Teutsch B, Bernstein KE, Corvol P, Clauser E (1993): Mutation of Asp74 of the rat angiotensin II receptor confers changes in antagonist affinities and abolishes G-protein coupling. Proc Natl Acad Sci USA 90:5133-5137.
16. 2 histamine receptor. Trends Pharmacol Sci 12:9-10.
17. Birkenbach M, Josefsen K, Yalamanchili R, Lenoir G, Kieff E (1993): Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors. J Virol 67:2209-2220.
18. s/adenylyl cyclase system. Mol Endocrinol 8:886-894.
19. Blount P, Krause JE (1993): The roles of the putative third cytoplasmic loop and cytoplasmic carboxyl tail of NK-1 and NK-2 receptors in agonist stimulated second messenger responses in stably transfected CHO cells. Regul Pept 46:447-449.
20. Blüml K, Mutschler E, Wess J (1994a): Identification of an intracellular tyrosine residue critical for muscarinic receptor-mediated stimulation of phosphatidylinositol hydrolysis. J Biol Chem 269:402-405.
21. Blüml K, Mutschler E, Wess J (1994b): Functional role in ligand binding and receptor activation of an asparagine residue present in the sixth transmembrane domain of all muscarinic acetylcholine receptors. J Biol Chem 269:18870-18876.
22. Blüml K, Mutschler E, Wess J (1994c): Insertion mutagenesis as a tool to predict the secondary structure of a muscarinic receptor domain determining specificity of G-protein coupling. Proc Natl Acad Sci USA 91:7980-7984.
23. Blüml K, Mutschler E, Wess J (1994d): Functional role of a cytoplasmic aromatic amino acid in muscarinic receptor-mediated activation of phospholipase C. J Biol Chem 269:11537-11541.
24. Bockstahler LE (1994): Overview of international PCR standardization efforts. PCR Methods Appl 3:263-267.
25. Bonner TI, Buckley NJ, Young AC, Brann MR (1987): Identification of a family of muscarinic acetylcholine receptor genes. Science 237:527-532.
26. Breu V, Hashido K, Broger C, Miyamoto C, Furuichi Y, Hayes A, Kalina B, Löffler BM, Ramuz H, Clozel M (1995): Separable binding sites for the natural agonist endothelin-1 and the nonpeptide antagonist bosentan on human enfothelin-A receptors. Eur J Biochem 231:266-270.
27. 2 dopamine receptor cDNA. Nature 336:783-787.
28. Burstein ES, Spalding TA, Hill-Eubanks D, Brann MR (1995): Structure-function of muscarinic receptor coupling to G proteins. J Biol Chem 270:3141-3146.
29. Caron MG, Kobilka BK, Frielle T, Bolanowski MA, Benovic JL, Lefkowitz RJ (1988): Cloning of the cDNA and genes for the hamster and human beta 2-adrenergic receptors. J Recept Res 8:7-21.
30. Chan T, Lee M, Sakmar TP (1992): Introduction of hydroxyl-bearing amino acids causes bathochromic spectral shifts in rhodopsin. Amino acid substitutions responsible for red-green color pigment spectral tuning. J Biol Chem 267:9478-9480.
31. Chini B, Mouillac B, Ala Y, Blaestre MN, Trumpp-Kallmeyer S, Hoflack J, Elands J, Hibert M, Manning M, Jard S, Barberis C (1995): Tyr115 is the key residue for determining agonist selectivity in the Via vasopressin receptor. EMBO J 14:2176-2182.
32. Choudhary MS, Craigo S, Roth BL (1992): Identification of receptor domains that modify ligand binding to 5-hydroxytryptamine 2 and 5-hydroxytryptamine 1c serotonin receptors. Mol Pharmacol 42:627-633.
33. 3H]ketanserin binding to 5-hydroxytryptamine 2 receptors. Mol Pharmacol 43:755-761.
34. Chung FZ, Wang CD, Potter PC, Venter JC, Fraser CM (1988): Site-directed mutagenesis and continuous expression of human beta-adrenergic receptors. Identification of a conserved aspartate residue involved in agonist binding and receptor activation. J Biol Chem 263:4052-4055.
35. Cohen GB, Oprian DD, Robinson PR (1992): Mechanism of activation and inactivation of opsin: role of Glu113 and Lys296. Biochemistry 31:12592-12601.
36. Cone RD, Mountjoy KG, Robbins LS, Nadeau JH, Johnson KR, Roselli RL, Mortrud MT (1993): Cloning and functional characterization of a family of receptors for the melanotropic peptides. Ann NY Acad Sci 680:342-363.
37. Corjay MH, Dobrzanski DJ, Way JM, Viallet J, Shapira H, Worland P, Sausville EA, Battey JF (1991): Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells. J Biol Chem 266:18771-18779.
38. Coughlin SR (1994): Expanding horizons for receptors coupled to G proteins: diversity and disease. Curr Opinion Cell Biol 6:191-197.
39. Cserzö M, Bernassau JM, Simon I, Maigret B (1994): New alignment strategy for transmembrane proteins. J Mol Biol 243:388-396.
40. 2 receptor: two molecular forms generated by alternative splicing. EMBO J 8:4025-4034.
41. Dalziel HH, Westfall DP (1994): Receptors for adenine nucleotides and nucleosides: Subclassification, Distribution, and Molecular Characterization. Pharmacol Rev 46:449-466.
42. 2 receptor from K562 (human chronic myelogenous leukemia) cells. J Pharmacol Exp Ther 271:1034-1041.
43. Davidson FF, Loewen PC, Khorana HG (1994a): Structure and function in rhodopsin: replacement by alanine of cysteine residues 110 and 187, components of a conserved disulfide bond in rhodopsin, affects the light-activated metarhodopsin II state. Proc Natl Acad Sci USA 91:4029-4033.
44. Davidson JS, Flanagan CA, Becker II, Illing N, Sealfon SC, Millar RP (1994b): Molecular function of the gonadotropin-releasing hormone receptor: insights from site-directed mutagenesis. Mol Cell Endocrinol 100:9-14.
45. 1 receptor gene - systematic screening for DNA-sequence variation and linkage mapping on chromosome 1q31-32.1 using a silent polymorphism in the coding region. Biochem Biophys Res Commun 214:614-621.
46. De Lean A, Stadel JM, Lefkowitz RJ (1980): A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor. J Biol Chem 255:7108-7117.
47. Dixon RAF, Kobilka BK, Strader DJ, Benovic JL, Dohlman HG, Frielle T, Bolanowski MA, Bennett CD, Rands E, Diehl RE, Mumford RA, Slater EE, Sigal IS, Caron MG, Lefkowitz RJ, Strader CD (1986): Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin. Nature 321:75-79.
48. Dixon RA, Sigal IS, Candelore MR, Register RB, Scattergood W, Rands E, Strader CD (1987): Structural features required for ligand binding to the beta-adrenergic receptor. EMBO J 6:3269-3275.
49. Dohlman HG, Caron MG, DeBlasi A, Frielle T, Lefkowitz RJ (1990): Role of extracellular disulfide-bonded cysteines in the ligand binding function of the beta 2-adrenergic receptor. Biochemistry 29:2335-2342.
50. Donnelly D, Findlay JBC (1994): Seven-helix receptors: structure and modelling. Curr Opinion Struct Biol 4:582-589.
51. Donnelly D, Findlay JBC, Blundell TL (1994): The evolution and structure of aminergic G protein-coupled receptors. Receptors Channels 2:61-78.
52. Drubbisch V, Lameh J, Philip M, Sharma YK, Sadee W (1992): Mapping the ligand binding pocket of the human muscarinic cholinergic receptor Hm1: contribution of tyrosine-82. Pharm Res 9:1644-1647.
53. Dryja TP, Berson EL, Rao VR, Oprian DD (1993): Heterozygous missense mutation in the rhodopsin gene as a cause of congenital stationary night blindness, Nat Genet 4:280-283.
54. Edwards MC, Gibbs RA (1994): Multiplex PCR: advantages, development, and applications. PCR Methods Appl 3:S65-S75.
55. Elling CE, Møller Nielsen S, Schwarte TW (1995): Conversion of antagonist binding site to metal-ion site in the tachykinin NK-1 receptor. Nature 374:74-77.
56. Ellis J, Seidenberg M, Brann MR (1993): Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions. Mol Pharmacol 44:583-588.
57. Emini EA, Hughes JV, Perlow DS, Boger J (1985): Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol 55:836-839.
58. 2U purinoceptors. Positively charged amino acids in transmembrane helices 6 and 7 affect agonist potency and specificity. J Biol Chem 270:4185-4188.
59. Faa V, Ventruto ML, Loche S, Bozzola M, Podda R, Cao A, Rosatelli MC (1994): Mutations in the vasopressin V2-receptor gene in three families of Italian descent with nephrogenic diabetes insipidus. Hum Mol Genet 3:1685-6.
60. Fahmy K, Siebert F, Sakmar TP (1995): Photoactivated state of rhodopsin and how it can form. Biophys Chem 56:171-81.
61. 1A receptor. Nature 335:358-360.
62. Fathi Z, Benya RV, Shapira H, Jensen RT, Battey JF (1993): The fifth transmembrane segment of the neuromedin B receptor is critical for high affinity neuromedin B binding. J Biol Chem 268:14622-14626.
63. Firsov D, Mandon B, Morel A, Merot J, Le Maout S, Bellanger AC, de Rouffignac C, Elalouf JM, Buhler JM (1994): Molecular analysis of vasopressin receptors in the rat nephron. Evidence for alternative splicing of the V2 receptor. Pflügers Arch Eur J Physiol 429:79-89.
64. 2 dopamine receptors and their chimaeras: analysis by subtype-specific antibodies. Biochem Biophys Res Commun 205:1460-1466.
65. Fong TM, Huang RR, Strader CD (1992a): Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor. J Biol Chem 267:25664-25667.
66. Fong TM, Yu H, Strader CD (1992b): Molecular basis for the species selectivity of the neurokinin-1 receptor antagonists CP-96,345 and RP67580. J Biol Chem 267:25668-25671.
67. Fong TM, Cascieri MA, Yu H, Bansal A, Swain C, Strader CD (1993a): Amino-aromatic interaction between histidine 197 of the neurokinin-1 receptor and CP 96345. Nature 362:350-353.
68. Fong TM, Huang RR, Yu H, Strader CD (1993b): Mapping the ligand binding site of the NK-1 receptor. Regul Pept 46:43-48.
69. Fong TM, Yu H, Cascieri MA, Underwood D, Swain CJ, Strader CD (1994a): The role of histidine 265 in antagonist binding to the neurokinin-1 receptor. J Biol Chem 269:2728-2732.
70. Fong TM, Yu H, Cascieri MA, Underwood D, Swain CJ, Strader CD (1994b) Interaction of glutamine 165 in the fourth transmembrane segment of the human neurokinin-1 receptor with quinuclidine antagonists. J Biol Chem 269:14957-14961.
71. Franke RR, Sakmar TP, Graham RM, Khorana HG (1992): Structure and function in rhodopsin. Studies of the interaction between the rhodopsin cytoplasmic domain and transducin. J Biol Chem 267:14767-14774.
72. Fraser CM, Chung FZ, Wang CD, Venter JC (1988): Site-directed mutagenesis of human beta-adrenergic receptors: substitution of aspartic acid-130 by asparagine produces a receptor with high-affinity agonist binding that is uncoupled from adenylate cyclase. Proc Natl Acad Sci USA 85:5478-5482.
73. Fraser CM (1989a): Site-directed mutagenesis of beta-adrenergic receptors. Identification of conserved cysteine residues that independently affect ligand binding and receptor activation. J Biol Chem 264:9266-9270.
74. Fraser CM, Wang CD, Robinson DA, Gocayne JD, Venter JC (1989b): Site-directed mutagenesis of ml muscarinic acetylcholine receptors: conserved aspartic acids play important roles in receptor function. Mol Pharmacol 36:840-847.
75. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M (1994): Pharmacol Rev 46:143-156.
76. Fredholm BB (1995): Purinoceptors in the nervous system. Pharmacol Toxicol 76:228-239.
77. 2 receptor allows discrimination between agonist and antagonist binding sites. Mol Pharmacol 44:934-939.
78. 2 receptor. Proc Natl Acad Sci USA 88:429-433.
79. 2 receptor. J Biol Chem 267: 20840-20843.
80. Garrett JE, Capuano IV, Hammerland LG, Hung BC, Brown EM, Hebert SC, Nemeth EF, Fuller F (1995): Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem 270:12919-12925.
81. Gershengorn MC (1993): Thyrotropin-releasing hormone receptor: cloning and regulation of its expression. Recent Prog Horm Res 48:341-363.
82. Gether U, Johansen TE, Schwartz TW (1993a): Chimeric NK1 (substance P)/NK3 (neurokinin B) receptors. Identification of domains determining the binding specificity of tachykinin agonists. J Biol Chem 268:7893-7898.
83. Gether U, Johansen TE, Snider RM, Lowe JA, Emonds-Alt X, Yokota Y, Nakanishi S, Schwartz TW (1993b): Binding epitopes for peptide and non-peptide ligands on the NK1 (substance P) receptor. Regul Pept 46:49-58.
84. Gether U, Nilsson L, Lowe JA, Schwartz TW (1994): Specific residues at the top of transmembrane segment V and VI of the neurokinin-1 receptor involved in binding of the nonpeptide antagonist CP 96,345. J Biol Chem 269:23959-23964.
85. Goujon L, Allevato G, Simonin G, Paquereau L, Le Cam A, Clark J, Nielsen JH, Djiane J, Postel-Vinay MC, Edery M, Kelly PA (1994): Cytoplasmic sequences of the growth hormone receptor necessary for signal transduction. Proc Natl Acad Sci USA 91: 957-961.
86. Guan XM, Peroutka JS, Kobilka BK (1992): Identification of a single amino acid residue responsible for the binding of a class of beta-adrenergic receptor antagonists to 5-hydroxytryptamine 1A receptors. Mol Pharmacol 41:695-698.
87. 2 receptor directs specificity of coupling to G-proteins. J Biol Chem 270:7354-7358.
88. Haraguchi K, Saito T, Kaneshige M, Endo T, Onaya T (1994a): Desensitization and internalization of a thyrotrophin receptor lacking the cytoplasmic carboxy-terminal region. J Mol Endocrinol 13:283-288.
89. Haraguchi K, Saito T, Endo T, Onaya T (1994b): Disruption of the first extracellular loop of thyrotropin receptor prevents ligand binding. Life Sci 55:961-968.
90. Harrison JK, Barber CM, Lynch KR (1994): cDNA cloning of a G-protein-coupled receptor expressed in rat spinal cord and brain related to chemokine receptors. Neurosci Lett 169:85-9.
91. Henderson R, Baldwin JM, Ceska TA, Zemlin F, Beckmann E, Downing KH (1990): Model for the structure of bacteriorhodopsin based on high-resolution electron cry-microscopy. J Mol Biol 213:899-929.
92. Hibert MF, Trumpp-Kallmeyer S, Bruinvels A, Hoflack J (1991): Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. Mol Pharmacol 40:8-15.
93. 2 receptor in a dominantly inherited bleeding disorder. J Clin Invest 94:1662-1667.
94. 1 receptor. J Biol Chem 269:30953-30959.
95. 1A receptor: a site-directed mutation study. FEBS Lett 312:259-262.
96. Hoflack J, Trumpp-Kallmeyer S, Hibert M (1994): Re-evaluation of bacteriorhodopsin as a model for G protein-coupled receptors. Trends Pharmacol Sci 43:348-350.
97. Honda Z, Nakamura M, Mild I, Minami M, Watanabe T, Seyama Y, Okado H, Toh H, Ito K, Miyamoto T, Shimizu T (1991): Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature 349:342-346.
98. 2-adrenergic receptors by sodium. J Biol Chem 265:21590-21595.
99. Houslay MD (1992): G-protein linked receptors: a family probed by molecular cloning and mutagenesis procedures. Clin Endocrinol 36:525-534.
100. 3 subtype in insect cells. Biochem J 307:493-498.
101. Hunyady L, Bor M, Balla T, Catt KJ (1995): Critical role of a conserved intramembrane tyrosine residue in angiotensin II receptor activation. J Biol Chem 270:9702-9705.
102. 1 receptor. Drug Des Discov 9:49-67.
103. Inagami T, Iwai N, Sasaki K, Yamamo Y, Bardhan S, Chaki S, Guo DF, Furuta H (1992): Cloning, expression and regulation of angiotensin II receptors. J Hypertens 10:713-716.
104. Intres R, Crabb JW (1992): Cloning strategies. Targeted Diagn Ther 7:43-53.
105. Ishihara T, Shigemoto R, Mon K, Takahashi K, Nagata S (1992). Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 8:811-819.
106. 2 receptor by the substituted-cysteine accessibility method. Neuron 14:825-831.
107. Jensen CJ, Gerard NP, Schwartz TW, Gether U (1994): The species selectivity of chemically distinct tachykinin nonpeptide antagonists is dependent on common divergent residues of the rat and human neurokinin-1 receptors. Mol Pharmacol 45:294-299.
108. Ji I, Ji TH (1991): Asp383 in the second transmembrane domain of the lutropin receptor is important for high affinity hormone binding and cAMP production. J Biol Chem 266:14953-14957.
109. 2a adenosine receptors are required for ligand recognition, submitted.
110. Jüppner H, Abou-Samra AB, Freeman M, Kong XF, Schipani E, Richards J, Kolakowski LF, Hock J, Potts JT, Kronenberg HM, Segre GV (1991): A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 254:1024-1026.
111. Kakar SS, Musgrove LC, Devor DC, Sellers JC, Neill JD (1992): Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor. Biochem Biophys Res Commun 189:289-295.
112. 2 receptor from a human to a rat pharmacology. FEBS Lett 307:324-328.
113. Karnik SS, Sakmar TP, Chen HB, Khorana HG (1988): Cysteine residues 110 and 187 are essential for the formation of correct structure in bovine rhodopsin. Proc Natl Acad Sci USA 85: 8459-8463.
114. Karnik SS, Ridge KD, Bhartacharya S, Khorana HG (1993): Palmitoylation of bovine opsin and its cysteine mutants in COS cells. Proc Natl Acad Sci USA 90:40-44.
115. Kaushal S, Khorana HG (1994): Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa. Biochemistry 33:6121-6128.
116. Kieffer BL, Befort K, Gaveriaux RC, Hirth CG (1992): The deltaopioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci USA 89: 12048-12052.
117. 3a adenosine receptor. J Biol Chem 270:13987-13997.
118. Kimura T, Azuma C, Takemura M, Inoue T, Kikuchi T, Kubota Y, Ogita K, Saji F, Tanizawa O (1993): Molecular cloning of a human oxytocin receptor. Regul Pept 45:73-77.
119. Kjelsberg MA, Cotecchia S, Ostrowski J, Caron MG, Lefkowitz RJ (1992): Constitutive activation of the alpha IB-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J Biol Chem 267: 1430-1433.
120. Klein PS, Sun TJ, Saxe CL, Kimmel AR, Johnson RL, Devreotes PN (1988): A chemoattractant receptor controls development in Dictyostelium discoideum. Science 241:1467-1472.
121. Knoers NV, van den Ouweland AM, Verdijk M, Monnens LA, van Oost BA (1994): Inheritance of mutations in the V2 receptor gene in thirteen families with nephrogenic diabetes insipidus. Kidney Int 46:170-176.
122. Kobilka BK, Frielle T, Collins S, Yang FT, Kobilka TS, Francke U, Lefkowitz RJ, Caron MG (1987): An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature 329:75-79.
123. Kobilka BK, Kobilka TS, Daniel K, Regan JW, Caron MG, Lefkowitz RJ (1988): Chimeric alpha 2-,beta-2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science 240:1310-1316.
124. Kolakowski LF (1994): GCRDb: a G-protein-coupled receptor database. Receptors Channels 2:1-7.
125. + regulation of agonist binding but does not alter receptor-G protein association. Mol Pharmacol 44:380-384.
126. Kosugi S, Okajima F, Ban T, Hidaka A, Shenker A, Kohn LD (1992): Mutation of alanine 623 in the third cytoplasmic loop of the rat thyrotropin (TSH) receptor results in a loss in the phosphoinositide but not cAMP signal induced by TSH and receptor autoantibodies. J Biol Chem 267:24153-24156.
127. Kosugi S, Shenker A, Mori T (1994): Constitutive activation of cyclic AMP but not phosphatidylinositol signaling caused by four mutations in the 6th transmembrane helix of the human thyrotropin receptor. FEBS Lett 356:291-294.
128. Kosugi S, Mori T (1994): The third exoplasmic loop of the thyrotropin receptor is partially involved in signal transduction. FEBS Lett 349:89-92.
129. 2 dopamine receptors. Distinct determinants of selective efficacy, potency, and signal transduction. J Biol Chem 269: 30299-30306.
130. Krystek JS, Patel PS, Rose PM, Fisher SM, Kienzle BK, Lach DA, Liu EC, Lynch JS, Novotny J, Webb ML (1994): Mutation of peptide binding site in transmembrane region of a G protein-coupled receptor accounts for endothelin receptor subtype selectivity. J Biol Chem 269:12383-12386.
131. Kubo T, Fukuda K, Mikama A, Maeda A, Takahashi H, Mishina M, Haga Y, Ichiyama A, Kangawa K, Kajima M, Matsuo H, Hirose T, Numa T (1986): Cloning, sequencing and expressing of complementary DNA coding the muscarinic acetylcholine receptor. Nature 323:411-416.
132. Kubo T, Bujo H, Akiba I, Nakai J, Mishina M, Numa S (1988): Location of a region of the muscarinic acetylcholine receptor involved in selective effector coupling. FEBS Lett 241:119-125.
133. Kunz D, Gerard NP, Gerard C (1992): The human leukocyte platelet-activating factor receptor. cDNA cloning, cell surface expression, and construction of a novel epitope-bearing analog. J Biol Chem 2679101-9106.
134. Kurtenbach E, Curtis CA, Pedder EK, Aitken A, Harris AC, Hulme EC (1990): Muscarinic acetylcholine receptors. Peptide sequencing identifies residues involved in antagonist binding and disulfide bond formation. J Biol Chem 265:13702-13708.
135. Kyte J, Doolittle RF (1982): A simple method for displaying the hydrophobic character of a protein. J Mol Biol 157:105-132.
136. La Rosa GJ, Thomas KM, Kaufmann ME, Mark R, White M, Taylor L, Gray G, Witt D, Navarro J (1992): Amino terminus of the interleukin-8 receptor is a major determinant of receptor subtype specificity. J Biol Chem 267:25402-25406.
137. Lattion AL, Diviani D, Cotecchia S (1994): Truncation of the receptor carboxyl terminus impairs agonist-dependent phosphorylation and desensitization of the alpha 1B-adrenergic receptor, J Biol Chem 269:22887-22893.
138. Laue L, Chan WY, Hsueh AJ, Kudo M, Hsu SY, Wu SM, Blomberg L, Cutler GJ (1995): Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty. Proc Natl Acad Sci USA 92:1906-1910.
139. Lee NH, Fraser CM (1993): Cross-talk between ml muscarinic acetylcholine and beta 2-adrenergic receptors. cAMP and the third intracellular loop of m1 muscarinic receptors confer heterologous regulation. J Biol Chem 268:7949-7957.
140. Lefkowitz RJ, Haber E, O'Hara D (1972): Identification of the cardiac beta-adrenergic receptor protein: solubilization and purification by affinity chromatography. Proc Natl Acad Sci USA 69:2828-2832.
141. Lefkowitz RJ, Cotecchia S, Samama P, Costa T (1993): Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci 14:303-7.
142. 1-receptor agonists. Biochem Biophys Res Commun 201: 295-301.
143. Li XJ, Forte M, North RA, Ross CA, Snyder SH (1992): Cloning and expression of a rat somatostatin receptor enriched in brain. J Biol Chem 267:21307-21312.
144. Li T, Franson WK, Gordon JW, Berson EL, Dryja TP (1995): Constitutive activation of phototransduction by K296E opsin is not a cause of photoreceptor degeneration. Proc Natl Acad Sci USA 92:3551-3555.
145. Libert F, Parmentier M, Lefort A, Dinsart C, Van Sande J, Maenhaut C, Simons MJ, Dumont JE, Vassart G (1989): Selective amplification and cloning of four new members of the G protein-coupled receptor family. Science 244:569-572.
146. Libert F, Schiffmann SN, Lefort A, Parmentier M, Gerard C, Dumont JE, Vanderhaeghen JJ, Vassart G (1991): The orphan receptor cDNA RDC7 encodes an A1 adenosine receptor. EMBO J 10:1677-1682.
147. Liggett SB, Freedman NJ, Schwinn DA, Lefkowitz RJ (1993): Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor. Proc Natl Acad Sci USA 90:3665-3669.
148. Lin SW, Sakmar TP, Franke RR, Khorana HG, Mathies RA (1992): Resonance Raman microprobe spectroscopy of rhodopsin mutants: effect of substitutions in the third transmembrane helix. Biochemistry 31:5105-5111.
149. Lin SW, Imamoto Y, Fukada Y, Shichida Y, Yoshizawa T, Mathies RA (1994): What makes red visual pigments red? A resonance Raman microprobe study of retinal chromophore structure in iodopsin. Biochemistry 33:2151-2160.
150. Linden J (1994): Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol Sci 15:298-306.
151. Link R, Daunt D, Barsh G, Chruscinski A, Kobilka B (1992): Cloning of two mouse genes encoding alpha 2-adrenergic receptor subtypes and identification of a single amino acid in the mouse alpha 2-C10 homolog responsible for an interspecies variation in antagonist binding. Mol Pharmacol 42:16-27.
152. Liu J, Schöneberg T, van Rhee AM, Wess J (1995): Mutational analysis of the relative orientation of transmembrane helices I and VII in G protein-coupled receptors. J Biol Chem. 13:133-154.
153. 4 receptor (DRD4) gene sequence within and among nonhuman primate species. Proc Natl Acad Sci USA 92:427-431.
154. 1C receptor by electrophysiological assays of mRNA-injected Xenopus oocytes. Proc Natl Acad Sci USA 84: 4332-4336.
155. Lustig KD, Shiau AK, Brake AJ, Julius D (1993): Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc Natl Acad Sci USA 90:5113-5117.
156. 347-to-alanine in a family with autosomal dominant retinitis pigmentosa indicates an important role for proline at position 347. Hum Mol Genetics 4:775-776.
157. 2-selective agonist. FEBS Lett 323:59-62.
158. 2 receptor with physiological constitutive activity. Biochem Biophys Res Commun 173:1169-1178.
159. 1D serotonin receptor. Biochem Biophys Res Commun 180:1460-1468.
160. Maggio R, Vogel Z, Wess J (1993): Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular cross-talk between G-protein-linked receptors. Proc Natl Acad Sci USA 90:3103-3107.
161. 1 receptor systems in rat hippocampal membranes. J Pharmacol Exp Therap 263:1275-1284.
162. 2 receptor. Eur J Pharmacol 227:205-214.
163. Mantamadiotis T, Baldwin GS (1994): The seventh transmembrane domain of gastrin/CCK receptors contributes to non-peptide antagonist binding. Biochem Biophys Res Commun 201:1382-1389.
164. Marsh L, Herskowitz I (1988): STE2 protein of Saccharomyces kluyveri is a member of the rhodopsin/beta-adrenergic receptor family and is responsible for recognition of the peptide ligand alpha factor. Proc Natl Acad Sci USA 85:3855-3859.
165. Masu M, Tanabe Y, Tsuchida K, Shigemoto R, Nakanishi S (1991): Sequence and expression of a metabotropic glutamate receptor-Nature 349:760-765.
166. 2 dopamine receptor expressed in CHO cells. FEBS Lett 24:81-86.
167. McEachern AE, Shelton ER, Bhakta S, Obernolte R, Bach C, Zuppan P, Fujisaki J, Aldrich RW. Jarnagin K (1991): Expression cloning of a rat B2 bradykinin receptor. Proc Natl Acad Sci USA 88:7724-7728.
168. 1 adenosine receptor from guinea pig brain. Brain Res Mol Brain Res 26:143-155.
169. Meyerhof W, Paust HJ, Schönrock C, Richter D (1991): Cloning of a cDNA encoding a novel putative G-protein-coupled receptor expressed in specific rat brain regions. DNA Cell Biol 10:689-694.
170. B receptors and C-terminal endothelin hexapeptide antagonists. J Mol Struct 333:243-248.
171. Millán JM, Fuchs S, Paricio N, Wedemann H, Gal A, Nájera C, Prieto F (1995): Gly114Asp mutation of rhodopsin in autosomal dominant retinitis pigmentosa. Mol Cell Probes 9:67-69.
172. Mills A, Duggan MJ (1994): Orphan seven transmembrane domain receptors: reversing pharmacology. Trends Biotechnol 12:47-49.
173. Min KC, Zvyaga TA, Cypess AM, Sakmar TP (1993): Characterization of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa. Mutations on the cytoplasmic surface affect transducin activation. J Biol Chem 268:9400-9404.
174. Miyajima I, Nakafuku M, Nakayama N, Brenner C, Miyajima A, Kaibuchi K, Arai K, Kaziro Y, Matsumoto K (1987): GPA1, a haploid-specific essential gene, encodes a yeast homolog of mammalian G protein which may be involved in mating factor signal transduction. Cell 50:1011-1019.
175. 1 Histamine Receptor Stably Expressed in CHO Cells. J Receptor & Signal Transduction Res 15:91-102.
176. Monden T, Yamada M, Satoh T, Iizuka M, Mori M (1992): Analysis of the TSH receptor gene structure in various thyroid disorders: DNA from thyroid adenomas can have large insertions or deletions. Thyroid 2:189-192.
177. 2 dopamine receptors produced by alternative RNA splicing. Nature 342:926-929.
178. Morel A, Lolait SJ, Brownstein MJ (1993): Molecular cloning and expression of rat V1a and V2 arginine vasopressin receptors. Regul Pept 45:53-59.
179. Moro O, Lameh J, Sadee W (1993): Serine- and threonine-rich domain regulates internalization of muscarinic cholinergic receptors. J Biol Chem 268:6862-6865.
180. 1 angiotensin receptors. Am J Hypertens 5:236S-242S.
181. Nathans J, Hogness DS (1983). Isolation, sequence analysis, and intron-exon arrangement of the gene encoding bovine rhodopsin. Cell 34:807-814.
182. 2 receptor affinity for drugs and inhibition of adenylyl cyclase. Mol Pharmacol 39:733-739.
183. O'Dowd BF, Hnatowich M, Regan JW, Leader WM, Caron MG. Lefkowitz RJ (1988): Site-directed mutagenesis of the cytoplasmic domains of the human beta 2-adrenergic receptor. Localization of regions involved in G protein-receptor coupling. J Biol Chem 263:15985-15992.
184. Ohno M, Endo T, Ohta K, Gunji K, Onaya T (1995): Point mutations in the thyrotropin receptor in human thyroid tumors. Thyroid 5:97-100.
185. 1 receptor: roles of aspartic acid 107, asparagine 198 and threonine 194. Biochem Biophys Res Commun 203:1096-1101.
186. 1B receptors. Nature 360:161-163.
187. Olah ME, Ren H, Ostrowski J, Jacobson KA, Stiles GL (1992): Cloning, expression, and characterization of the unique bovine A1 adenosine receptor. Studies on the ligand binding site by site-directed mutagenesis. J Biol Chem 267:10764-10770.
188. Olah ME, Jacobson KA, Stiles GL (1994a): Identification of an adenosine receptor domain specifically involved in binding of 5́-substituted adenosine agonists. J Biol Chem 269:18016-18020.
189. 3 adenosine receptors. J Biol Chem 269:24692-24698.
190. Oliveira L, Paiva ACM, Vriend G (1993): A common motif in G-protein-coupled seven transmembrane helix receptors. J Comp-Aided Mol Design 7:649-658.
191. Orwell G (1945): Animal Farm: a fairy story. Seeker & Warburg: London.
192. Ostrowski J, Kjelsberg MA, Caron MG, Lefkowitz RJ (1992): Mutagenesis of the beta 2-adrenergic receptor: how structure elucidates function. Ann Rev Pharmacol Toxicol 32:167-183.
193. Ozenberger BA, Hadcock JR (1995): A single amino acid substitution in somatostatin receptor subtype 5 increases affinity for somatostatin-14. Mol Pharmacol 47:82-87.
194. Page KM, Curtis CAM, Jones PG, Hulme EC (1995): The functional role of the binding-site aspartate in muscarinic acetylcholine-receptors probed by site-directed mutagenesis. Eur J Pharmacol-Mol Pharmacol Sect 289:429-437.
195. Pan Y, Metzenberg A, Das S, Jing B, Gitschier J (1992): Mutations in the V2 vasopressin receptor gene are associated with X-linked nephrogenic diabetes insipidus. Nat Genet 2:103-106.
196. Parker EM, Grisel DA, Iben LG, Shapiro RA (1993): A single amino acid difference accounts for the pharmacological distinctions between the rat and human 5-hydroxytryptamine 1B receptors. J Neurochem 60:380-383.
197. Parma J, Duprez L, van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J, Vassart G (1993): Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365:649-651.
198. Parmentier M, Libert F, Perret J, Eggerickx D, Ledent C, Schurmans S, Raspe E, Dumont JE, Vassart G (1993): Cloning and characterization of G protein-coupled receptors. Adv Second Messenger Phosphoprotein Res 28:11-18.
199. Paschke R, Tonacchera M, van Sande J, Parma J, Vassart G (1994a): Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid. J Clin Endocrinol Metab 79:1785-1789.
200. Paschke R, Parmentier M, Vassart G (1994b): Importance of the extracellular domain of the human thyrotrophin receptor for activation of cyclic AMP production. J Mol Endocrinol 13:199-207.
201. Peralta EG, Ashkenazi A, Winslow JW, Smith DH, Ramachandran J, Capon DJ (1987): Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. EMBO J 6:3923-3929.
202. Perlman JH, Nussenzveig DR, Osman R, Gershengorn MC (1992): Thyrotropin-releasing hormone binding to the mouse pituitary receptor does not involve ionic interactions. A model for neutral peptide binding to G protein-coupled receptors. J Biol Chem 267:24413-24417.
203. Perlman JH, Thaw CN, Laakkonen L, Bowers CY, Osman R, Gershengorn MC (1994a): Hydrogen bonding interaction of thyrotropin-releasing hormone (TRH) with transmembrane tyrosine 106 of the TRH receptor. J Biol Chem 269:1610-1613.
204. Perlman JH, Laakkonen L, Osman R, Gershengorn MC (1994b): A model of the thyrotropin-releasing hormone (TRH) receptor binding pocket. Evidence for a second direct interaction between transmembrane helix 3 and TRH. J Biol Chem 269: 23383-6.
205. Perlman JH, Laakkonen L, Osman R, Gershengorn MC (1995a): Distinct roles for arginines in transmembrane helices 6 and 7 of the thyrotropin-releasing hormone receptor. Mol Pharmacol 47: 480-484.
206. Perlman S, Schambye HT, Rivero RA, Greenlee WJ, Hjorth SA, Schwartz TW (1995b): Non-peptide angiotensin agonist. Functional and molecular interaction with the AT1 receptor. J Biol Chem 270:1493-1496.
207. Pin JP, Gomeza J, Joly C, Bockaert J (1995): The metabotropic glutamate receptors: their second intracellular loop plays a critical role in the G-protein coupling specificity. Biochem Soc Trans 23:91-96.
208. Pittel Z, Wess J (1994): Intramolecular interactions in muscarinic acetylcholine receptors studied with chimeric m2/m5 receptors. Mol Pharmacol 45:61-64.
209. 1 receptor affect ligand interactions and receptor activation. J Biol Chem 267:17780-17786.
210. Probst WC, Snyder LA, Schuster DI, Brosius J, Sealfon SC (1992): Sequence alignment of the G-protein coupled receptor super-family. DNA Cell Biol 11:1-20.
211. Prusis P, Fr̈andberg PA, Muceniece R, Kalvinsh I, Wikberg JES (1995): A three dimensional model for the interaction of MSH with the melanocortin-1 receptor. Biochem Biophys Res Commun 210:205-210.
212. Quintana J, Wang H, Ascoli M (1993): The regulation of the binding affinity of the luteinizing hormone/choriogonadotropin receptor by sodium ions is mediated by a highly conserved aspartate located in the second transmembrane domain of G protein-coupled receptors. Mol Endocrinol 7:767-775.
213. Rashtchian A (1995): Novel methods for cloning and engineering genes using the polymerase chain reaction. Curr Opin Biotechnol 6:30-36.
214. 2 receptor. J Biol Chem 269:19256-19261.
215. Raymond JR (1994): Hereditary and acquired defects in signaling through the hormone-receptor-G protein complex. Am J Physiol 226:F163-F174.
216. Ren Q, Kurose H, Lefkowitz RJ, Cotecchia S (1993): Constitutively active mutants of the alpha 2-adrenergic receptor. J Biol Chem 268:16483-16487.
217. 1 adenosine receptor expression. Proc Natl Acad Sci USA 91:4864-4866.
218. Resek JF, Farrens D, Khorana HG (1994): Structure and function in rhodopsin: covalent crosslinking of the rhodopsin (metarhodopsin II)-transducin complex - the rhodopsin cytoplasmic face links to the transducin alpha subunit. Proc Natl Acad Sci USA 91:7643-7647.
219. Richards JE, Scott KM, Sieving PA (1995): Disruption of conserved rhodopsin disulfide bond by Cys187Tyr mutation causes early and severe autosomal dominant retinitis pigmentosa. Ophthalmol. 102:669-677.
220. Richardson JS, Richardson DC (1988): Amino acid preferences for specific locations at the ends of a helices. Science 240:1648-1652.
221. Ridge KD, Bhattacharya S, Nakayama TA, Khorana HG (1992): Light-stable rhodopsin. II. An opsin mutant (Trp265→Phe) and a retinal analog with a nonisomerizable 11-cis configuration form a photostable chromophore. J Biol Chem 267:6770-6775.
222. Ridge KD, Lu Z, Liu X, Khorana HG (1995): Structure and function in rhodopsin. Separation and characterization of the correctly folded and misfolded opsins produced on expression of an opsin mutant gene containing only the native intradiscal cysteine codons. Biochemistry 34:3261-3267.
223. Robbins LS, Nadeau JH, Johnson KR, Kelly MA, Roselli RL, Baack E, Mountjoy KG, Cone RD (1993): Pigmentation pheno-types of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 72:827-834.
224. Robinson PR, Cohen GB, Zhukovsky EA, Oprian DD (1992): Constitutively Active Mutants of Rhodopsin. Neuron 9:719-725.
225. 3 receptor: chimeric receptors delineate a role for intracellular domains. Mol Pharmacol 46:352-356.
226. Rollins PJ, Turner SJ, Akpoguma CI, Ray KP (1994): Characterisation of human adenosine type 1, 2a and 2b receptors expressed in CHO cells. Biochem Soc Trans 22:1955.
227. B receptor subtype-selective ligand binding while abolishing phospholipase C activation in both receptors. FEBS Lett 361:243-249.
228. Rosenkilde MM, Cahir M, Gether U, Hjorth SA, Schwartz TW (1994): Mutations along transmembrane segment II of the NK-1 receptor affect substance P competition with non-peptide antagonists but not substance P binding. J Biol Chem 269:28160-28164.
229. Rosenthal W, Antaramian A, Gilbert S, Birnbaumer M (1993): Nephrogenic diabetes insipidus. A V2 vasopressin receptor unable to stimulate adenylyl cyclase. J Biol Chem 268:13030-13033.
230. 2 receptor gene in families with naphrogenic diabetes insipidus and functional expression of the Q-2 mutant. Cell Mol Biol 40:429-436.
231. Ross PC, Figler RA, Corjay MH, Barber CM, Adam N, Harcus DR, Lynch KR (1990): RTA, a candidate G protein-coupled receptor: cloning, sequencing, and tissue distribution. Proc Natl Acad Sci USA 87:3052-6.
232. 2-receptor gene. Biochem Biophys Res Commun 179:1470-1478.
233. Sachais BS, Snider RM, Lowe JA, Krause JE (1993): Molecular basis for the species selectivity of the substance P antagonist CP-96,345. J Biol Chem 268:2319-2323.
234. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N (1985): Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230:1350-1354.
235. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA (1988): Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491.
236. 3 adenosine receptor. Proc Natl Acad Sci USA 90:10365-10369.
237. Samama P, Cotecchia S, Costa T, Lefkowitz RJ (1993): A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. J Biol Chem 268:4625-4636.
238. 2 dopamine receptors in Sf21 cells. Biochem Soc Trans 23:89S.
239. Sankararamakrishnan R, Vishveshwara S (1992): Geometry of proline-containing alpha-helices in proteins. Int J Peptide Protein Res 39:356-363.
240. Sasakawa N, Sharif M, Hanley MR (1994): Attenuation of agonistinduced desensitization of the rat substance P receptor by progressive truncation of the C-terminus. FEBS Lett 347:181-184.
241. Savarese TM, Wang CD, Fraser CM (1992): Site-directed mutagenesis of the rat ml muscarinic acetylcholine receptor. Role of conserved cysteines in receptor function. J Biol Chem 267: 11439-11448.
242. Schertler GF, Villa C, Henderson R (1993): Projection structure of rhodopsin. Nature 362:770-772.
243. Schwartz TW (1994): Locating ligand-binding sites in 7TM receptors by protein engineering. Curr Opinion Biotechnol 5:434-444.
244. Shapiro RA, Palmer D, Cislo T (1993): A deletion mutation in the third cytoplasmic loop of the mouse ml muscarinic acetylcholine receptor unmasks cryptic G-protein binding sites. J Biol Chem 268:21734-21738.
245. Shenker A, Laue L, Kosugi S, Merendino JJ, Minegishi T, Cutler GJ (1993): A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 365:652-654.
246. 2, receptors. J Chem Neuroanat 5:281-282.
247. Strader CD, Sigal IS, Register RB, Candelore MR, Rands E, Dixon RA (1987a): Identification of residues required for ligand binding to the beta-adrenergic receptor. Proc Natl Acad Sci USA 84:4384-4388.
248. s and increase agonist affinity. J Biol Chem 262: 16439-16443.
249. Strader CD, Sigal IS, Candelore MR, Rands E, Hill WS, Dixon RA (1988): Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function. J Biol Chem 263:10267-10271.
250. Strader CD, Candelore MR, Hill WS, Dixon RA, Sigal IS (1989a): A single amino acid substitution in the beta-adrenergic receptor promotes partial agonist activity from antagonists. J Biol Chem 264:16470-16477.
251. Strader CD, Candelore MR, Hill WS, Sigal IS, Dixon RA (1989b): Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor. J Biol Chem 264:13572-13578.
252. Strader CD, Gaffney T, Sugg EE, Candelore MR, Keys R, Patchett AA, Dixon RA (1991): Allele-specific activation of genetically engineered receptors. J Biol Chem 266:5-8.
253. Strader CD, Fong TM, Tota MR, Underwood D, Dixon RAF (1994): Structure and function of G protein-coupled receptors. Ann Rev Biochem 63:101-132.
254. Straub RE, Frech GC, Joho RH, Gershengorn MC (1990): Expression cloning of a cDNA encoding the mouse pituitary thyrotropin-releasing hormone receptor. Proc Natl Acad Sci USA 87:9514-9518.
255. Sugimoto Y, Namba T, Honda A, Hayashi Y, Negishi M, Ichikawa A, Narumiya S (1992): Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype. J Biol Chem 267: 6463-6466.
256. 2-adrenoceptor that blocks coupling to potassium but not calcium currents. Science 257:977-980.
257. Suryanarayana S, Daunt DA, von Zastrow M, Kobilka BK (1991): A point mutation in the seventh hydrophobic domain of the alpha 2 adrenergic receptor increases its affinity for a family of beta receptor antagonists. J Biol Chem 266:15488-15492.
258. Suryanarayana S, Kobilka BK (1993): Amino acid substitutions at position 312 in the seventh hydrophobic segment of the beta 2-adrenergic receptor modify ligand-binding specificity. Mol Pharmacol 44:111-114.
259. 20 serotonin receptors. Nature 374:542-546.
260. 2 receptor and its testing by docking of agonists and tricyclic antagonists. J Med Chem 37:2874-88.
261. 116 (TM3) has a constitutive role in receptor stimulation. J Computer-Aided Mol Design 9:319-330.
262. Thomas KM, Pyun HY, Navarro J (1990): Molecular cloning of the fMet-Leu-Phe receptor from neutrophils. J Biol Chem 265: 20061-20064.
263. 1 adenosine receptor mediates specific agonist binding. J Biol Chem 269:2373-2376.
264. Trumpp-Kallmeyer S, Hoflack J, Bruinvels A, Hibert M (1992): Modeling of G-Protein-Coupled Receptors - Application to Dopamine, Adrenaline, Serotonin, Acetylcholine, and Mammalian Opsin Receptors. J Med Chem 35:3448-3462.
265. Tsukaguchi H, Matsubara H, Aritaki S, Kimura T, Abe S, Inada M (1993): Two novel mutations in the vasopressin V2 receptor gene in unrelated Japanese kindreds with nephrogenic diabetes insipidus. Biochem Biophys Res Commun 197:1000-1010.
266. Tucker AL, Robeva AS, Taylor HE, Holeton D, Bockner M, Lynch KR, Linden J (1994): A1 adenosine receptors. Two amino acids are responsible for species differences in ligand recognition. J Biol Chem 269:27900-6.
267. Turki J, Pak J, Green SA, Martin RJ, Liggett SB (1995): Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype. J Clin Invest 95:1635-1641.
268. 1 receptor ligands - a test-case for distributed multipole analysis in medicinal chemistry. J Comp Aided Mol Design 9:44-54.
269. 2 receptors: structure-function relationships. Med Res Rev 12:423-471.
270. i guanine-nucleotide-binding regulatory protein regulate receptor internalization. Eur J Biochem 222:525-531.
271. 2y purinoceptor using rhodopsin as template. Drug Design Discovery. In press.
272. Venter JC, Fraser CM (1983): beta-Adrenergic receptor isolation and characterization with immobilized drugs and monoclonal antibodies. Fed Proc 42:273-278.
273. Vigna SR, Bowden JJ, McDonald DM, Fisher J, Okamoto A, McVey DC, Payan DG, Bunnett NW (1994): Characterization of antibodies to the rat substance P (NK-1) receptor and to a chimeric substance P receptor expressed in mammalian cells. J Neurosci 14:834-845.
274. von Heijne G, Manoil C (1990): Membrane proteins: from sequence to structure. Protein Eng. 4:109-112.
275. von Heijne G (1991): Proline kinks in transmembrane α-helices. J Mol Biol 218:499-503.
276. von Zastrow M, Kobilka BK (1994): Antagonist-dependent and -independent steps in the mechanism of adrenergic receptor internalization. J Biol Chem 269:18448-18452.
277. Vosberg HP (1989): The polymerase chain reaction: an improved method for the analysis of nucleic acids. Hum Genet 83:1-15.
278. Vouret-Craviari V, Grail D, Chambard JC, Rasmussen UB, Pouyssegur J, van Obberghen-Schilling E (1995): Post-translational and activation-dependent modifications of the G protein-coupled thrombin receptor. J Biol Chem 270:8367-8372.
279. Vu TK, Hung DT, Wheaton VI, Coughlin SR (1991): Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057-1068.
280. 4-tetraphosphate receptor. Biochemistry 32.3119-3123.
281. Wang H, Lipfert L, Malbon CC, Bahouth S (1989): Site-directed anti-peptide antibodies define the topography of the beta-adrenergic receptor. J Biol Chem 264:14424-14431.
282. Wang CD, Buck MA, Fraser CM (1991): Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists. Mol Pharmacol 40:168-179.
283. Wang CD, Gallaher TK, Shih JC (1993a): Site-directed mutagenesis of the serotonin 5-hydroxytrypamine 2 receptor: Identification of amino acids necessary for ligand binding and receptor activation. Mol Pharmacol 43:931-940.
284. Wang Z, Wang H, Ascoli M (1993b): Mutation of a highly conserved acidic residue present in the second intracellular loop of G-protein-coupled receptors does not impair hormone binding or signal transduction of the luteinizing hormone/chorionic gonadotropin receptor. Mol Endocrinol 7:85-93.
285. Wang X, Souza SC, Kelder B, Cioffi JA, Kopchick JJ (1995): A 40-amino acid segment of the growth hormone receptor cytoplasmic domain is essential for GH-induced tyrosine-phosphorylated cytosolic proteins. J Biol Chem 270:6261-6266.
286. Wank SA, Harkins R, Jensen RT, Shapira H, de Weerth A, Slattery T (1992): Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. Proc Natl Acad Sci USA 89:3125-3129.
287. Webb TE, Simon J, Krishek BJ, Bateson AN, Smart TG, King BF, Burnstock G, Barnard EA (1993): Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett 324:219-25.
288. Weitz CJ, Nathans J (1992): Histidine residues regulate the transition of photoexcited rhodopsin to its active conformation, metarhodopsin II. Neuron 8:465-472.
289. Wess J, Brann MR, Bonner TI (1989): Identification of a small intracellular region of the muscarinic m3 receptor as a determinant of selective coupling to PI turnover. FEBS Lett 258:133-136.
290. Wess J, Gdula D, Brann MR (1991): Site-directed mutagenesis of the m3 muscarinic receptor: Identification of a series of threonine and tyrosine residues involved in agonist but not antagonist binding. EMBO J 10:3729-3734.
291. Wess J, Gdula D, Brann MR (1992a): Structural basis of the subtype selectivity of muscarinic antagonists : A study with chimeric m2/m5 muscarinic receptors. Mol Pharmacol 41:369-74.
292. Wess J, Maggio R, Palmer JR, Vogel Z (1992b): Role of conserved threonine and tyrosine residues in acetylcholine binding and muscarinic receptor activation. A study with m3 muscarinic receptor point mutants. J Biol Chem 267:19313-19319.
293. Wess J, Nanavati S, Vogel Z, Maggio R (1993): Functional role of proline and tryptophan residues highly conserved among G protein-coupled receptors studied by mutational analysis of the m3 muscarinic receptor. EMBO J 12:331-338.
294. White TJ, Arnheim N, Erlich HA (1989): The polymerase chain reaction. Trends Genet 5:185-189.
295. White SH, Jacobs RE (1990): Observations concerning topology and locations of helix ends of membrane proteins of known structure. J Membrane Biol 115:145-158.
296. Wildin RS. Antush MJ, Bennett RL, Schoof JM, Scott CR (1994): Heterogeneous AVPR2 gene mutations in congenital nephrogenic diabetes insipidus. Am J Hum Genet 55:266-277.
297. Wong SK, Slaughter C, Ruoho AE, Ross EM (1988): The catecholamine binding site of the beta-adrenergic receptor is formed by juxtaposed membrane-spanning domains. J Biol Chem 263: 7925-7928.
298. Wong SK, Ross EM (1994): Chimeric muscarinic cholinergic: betaadrenergic receptors that are functionally promiscuous among G proteins. J Biol Chem 269:18968-18976.
299. Wu LH, Vartanian MA, Oxender DL, Chung FZ (1994): Identification of methionine134 and alanine146 in the second transmembrane segment of the human tachykinin NK3 receptor as reduces involved in species-selective binding to SR 48968. Biochem Biophys Res Commun 198:961-966.
300. Yamano Y, Ohyama K, Chaki S, Guo DF, Inagami T (1992): Identification of amino acid residues of rat angiotensia II receptor for ligand binding by site directed mutagenesis. Biochem Biophys Res Commun 187:1426-1431.
301. Yamano Y, Ohyama K, Kikyo M, Sano T, Nakagomi Y, Inoue Y, Nakamura N, Morishima I, Guo DF, Hamakubo T, Inagami T (1995): Mutagenesis and the molecular modeling of the rat angiotensin II receptor (AT1). J Biol Chem 270:14024-14030.
302. Yamashita M, Fukui H, Sugama K, Horio Y, Ito S, Mizuguchi H, Wada H (1991): Expression cloning of a cDNA encoding the bovine histamine H1 receptor. Proc Natl Acad Sci USA 88: 11515-11519.
303. Yano K, Saji M, Hidaka A, Moriya N, Okuno A, Kohn LD, Cutler GJ (1995): A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty. J Clin Endocrinol Metab 80:1162-1168.
304. Ye RD, Prossnitz ER, Zou AH, Cochrane CG (1991): Characterization of a human cDNA that encodes a functional receptor for platelet activating factor. Biochem Biophys Res Commun 180: 105-111.
305. Yokota Y, Sasai Y, Tanaka K, Fujiwara T, Tsuchida K, Shigemoto R, Kakizuka A, Ohkubo H, Nakanishi S (1989): Molecular characterization of a functional cDNA for rat substance P receptor. J Biol Chem 264:17649-17652.
306. Yokoyama R, Knox BE, Yokoyama S (1995): Rhodopsin from the fish, Astyanax: Role of tyrosine 261 in the red shift. Invest Ophthalmol Vis Sci 36:939-945.
307. Zhang D, Weinstein H (1994): Polarity conserved positions in transmembrane domains of G-protein coupled receptors and bacteriorhodopsin. FEBS Lett 337:207-212.
308. Zhou W, Flanagan C, Ballesteros JA, Konvicka K, Davidson JS, Weinstein H, Millar RP, Sealfon SC (1994): A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor. Mol Pharmacol 2:165-170.
309. Zhu G, Wu LH, Mauzy C, Egloff AM, Mirzadegan T, Chung FZ (1992): Replacement of lysine-181 by aspartic acid in the third transmembrane region of endothelin type B receptor reduces its affinity to endothelin peptides and sarafotoxin 6c without affecting G protein coupling. J Cell Biochem 50:159-164.
310. Zhukovsky EA, Oprian DD (1989): Effect of carboxylic acid side chains on the absorption maximum of visual pigments. Science 246:928-930.
311. Zoffmann S, Gether U, Schwartz TW (1993): Conserved HisVI-17 of the NK-1 receptor is involved in binding of non-peptide antagonists but not substance P. FEBS Lett 336:506-510.
312. Zvyaga TA, Min KC, Beck M, Sakmar TP (1993): Movement of the retinylidene Schiff base counterion in rhodopsin by one helix turn reverses the pH dependence of the metarhodopsin I to metarhodopsin II transition. J Biol Chem 268:4661-4667.